Colorectal carcinoma screening attitudes and practices among primary care physicians in counties at extremes of either high or low cancer case-fatality.
BACKGROUND
To the authors' knowledge, physician attitudes and reported practices regarding colorectal carcinoma screening have not been studied in areas of highest risk for cancer death.


METHODS
Medicare claims were used to calculate colorectal carcinoma 2-year case-fatality rates for counties with >100 incident cases of colorectal carcinoma between 1991-1993. All 2682 practicing primary care physicians in 20 counties with the lowest case-fatality rates (mean of 29.9%) and 19 counties with the highest case-fatality rates (mean of 47.8%) were surveyed regarding their screening procedures and attitudes.


RESULTS
Among the 972 respondents (36.1%), the reported use of fecal occult blood testing (FOBT) and flexible sigmoidoscopy was similar in the low and high case-fatality counties. However, physicians who practiced in the high case-fatality counties were less likely to be trained in and to perform sigmoidoscopy themselves (37.0% vs. 45.6%; P<0.01). Moreover, practitioners in the high case-fatality counties were more likely than the other physicians to consider or plan enhanced FOBT and sigmoidoscopic screening in the near future. FOBT and sigmoidoscopy screening rates at the county level were associated negatively with cancer incidence rates, case-fatality rates, and metastatic disease rates, suggesting a potentially protective effect.


CONCLUSIONS
Geographically targeted interventions are a potentially cost-effective strategy for focusing additional screening services on the highest risk populations. The primary care clinicians in these high risk areas are logical partners for these interventions by virtue of their high degree of readiness to change their current screening practices.
Cooper
G S
GS
Department of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
Yuan
Z
Z
Veri
L
L
Rimm
A A
AA
Stange
K C
KC
D001294:Attitude to Health; D015179:Colorectal Neoplasms / Q000175:diagnosis / Q000517:prevention & control*; D016208:Databases, Factual; D017408:Guidelines as Topic; D006801:Humans; D008403:Mass Screening / Q000706:statistics & numerical data*; D006278:Medicare; D009026:Mortality; D009780:Occult Blood; D010821:Physicians, Family / Q000706:statistics & numerical data*; D010818:Practice Patterns, Physicians'; D012307:Risk Factors; D014481:United States